MARKET

TRIB

TRIB

Trinity Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.630
-0.010
-0.38%
After Hours: 2.620 -0.01 -0.38% 19:56 08/07 EDT
OPEN
2.670
PREV CLOSE
2.640
HIGH
2.670
LOW
2.540
VOLUME
383.49K
TURNOVER
--
52 WEEK HIGH
3.277
52 WEEK LOW
0.5610
MARKET CAP
63.23M
P/E (TTM)
-1.7732
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TRIB stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.

EPS

TRIB News

More
Edited Transcript of TRIB earnings conference call or presentation 27-May-20 3:00pm GMT
Q1 2020 Trinity Biotech PLC Earnings Call
Thomson Reuters StreetEvents · 07/24 00:40
The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)
Benzinga · 07/21 11:59
81 Biggest Movers From Yesterday
Gainers Electrameccanica Vehicles Corp. (NASDAQ: SOLO) climbed 64.5% to close at $5.15 on Monday after jumping more than 34% on Thursday.
Benzinga · 07/07 09:10
62 Stocks Moving In Monday's Mid-Day Session
Gainers Ayro, Inc. (NASDAQ: AYRO) shares jumped 105.8% to $6.73 after the company completed its factory expansion that will allow it to handle up to 600 EVs per month, compared to only 200 per month before the expansion.
Benzinga · 07/06 16:26
Penny Stocks to Buy Using Technical Analysis for July 2020
In these challenging times, a familiarity with the tools of technical analysis can be invaluable for zeroing in on profitable stocks.
Investopedia · 06/30 16:59
GNW, IIPR among premarket losers
Seeking Alpha - Article · 06/30 12:15
NKLA, COTY among premarket gainers
Seeking Alpha - Article · 06/29 12:24
Edited Transcript of TRIB earnings conference call or presentation 31-Mar-20 3:00pm GMT
Thomson Reuters StreetEvents · 06/02 11:17

Industry

Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.49%

Hot Stocks

Symbol
Price
%Change

About TRIB

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
More

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.